The following Synthego products are covered by one or more patents or patent applications in the United States and in other countries. This webpage is provided to comply with the virtual marking provisions of various jurisdictions including the America Invents Act codified under 35 U.S. Code Section 287(a). The following list of products may not be all inclusive. There may be additional patents or patent applications covering these Synthego products. Other Synthego products not listed here may be protected by one or more patents.
AccuBase™ is covered by one or more of the following patents: US 12,123,006 B2; US 12,134,771 B2; CN ZL202010163058.3; and CN ZL202111413824.8. These patents are owned by Base Therapeutics. The product is manufactured by KactusBio and distributed by Synthego. Additional patent applications may be pending.
For use under US Application Nos. 18/439,897 and 18/559,598; exclusively licensed to Synthego from AstraZeneca AB.
eSpOT-ON Nuclease purchased from Synthego is intended to be used solely with compatible guide RNAs purchased from Synthego.
For use under US Application Nos. 18/439,897 and 18/559,598; exclusively licensed to Synthego from AstraZeneca AB.
eSpOT-ON guide RNAs purchased from Synthego are intended to be used solely with eSpOT-ON Nuclease purchased from Synthego.
For use under US 11,649,444; exclusively licensed to Synthego from Huidagene. Additional patents pending in the United States also exclusively licensed to Synthego from Huidagene.
hfCas12Max Nuclease purchased from Synthego is only intended and licensed to be used solely with hfCas12Max guide RNAs purchased from Synthego.
For use under US 11,649,444; exclusively licensed to Synthego from Huidagene. Additional patents pending in the United States also exclusively licensed to Synthego from Huidagene.
hfCas12Max guide RNAs purchased from Synthego are only intended and licensed to be used solely with hfCas12Max Nuclease purchased from Synthego.
Cart
Account
Your Orders
Sign In
